Condition: Fecal Microbiota Transplantation (FMT) · Gastrointestinal Neoplasms · Antineoplastic Agents · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The goal of this clinical trial is to learn if fecal microbiota transplantation can treat in Gastrointestinal cancer patients with chemotherapy / targeted gastrointestinal symptoms. The main question it aims to answer is: To evaluate the effect of fecal microbiota transplantation (FMT) on gastrointestinal tract in patients with gastrointestinal tumors.
This description comes directly from the study's public registry record.
Da Wang · 86-0571-87784720 · wangda0618@zju.edu.cn
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital Zhejiang University School of Medicine | Zhejiang, Hangzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07319364